No images? Click here In This Issue - October 2023
![]() UPDATE: PCAL Recruitment is Open for 2024!The Niagara Region Public Health Primary Care Advisory and Liaison (PCAL) Group is made up of Public Health representatives, family physicians, and nurse practitioners. This group is in place to support improved two-way communication between Niagara Region Public Health and Niagara’s primary care sector, including collaboration efforts, resource sharing, and knowledge exchange. It is an excellent opportunity to work collaboratively on addressing community-health related issues. We are looking for new members to join PCAL in 2024! Time Commitment & Responsibilities
How to Join & More Information
![]() UPDATE: 2023 / 2024 Influenza Immunization ProgramThe Ministry of Health has updated the Universal Influenza Immunization Program (UIIP) website with information on product availability, distribution and vaccine supply. Health Care Provider Action
More Information Visit our website or call the Vaccine Preventable Disease program at 905-688-8248 or 1-888-505-6074 ext. 7396. UPDATE: Respiratory SurveillanceSurveillance Update: Influenza Activity is Low
2023-2024 Respiratory Season ![]() Data source: Public Health Ontario’s Ontario Respiratory Virus Tool, data as of October 14th, 2023. Please note: Coronavirus refers to non-pandemic human coronaviruses. Provincially, SARS-CoV-2 is the most commonly circulating virus amongst samples analyzed. Niagara reports flu activity surveillance information weekly on Fridays. For more detail on the 2023 to 2024 respiratory season, please visit Public Health Ontario’s page for the Ontario Respiratory virus Tool. UPDATE: Health Canada Safety Review: Domperidone and Risk of Psychiatric Withdrawal EventsIn October 2023, Health Canada issued a review of the research relating to psychiatric withdrawal events following sudden discontinuation or tapering (dose reduction) of domperidone used to stimulate lactation. Events may include, but are not limited to, depression, anxiety, and insomnia. Health Canada’s review of the available information found a link between the sudden discontinuation or tapering of domperidone, used off-label for lactation stimulation, and the risk of psychiatric withdrawal events. This link was mostly observed in patients taking daily doses greater than the maximum recommended dose of 30 mg per day. Please note, the review was limited by the small number of cases. More Information
REVIEW: Antiviral Medication for the 2023-2024 Respiratory SeasonHealth care providers are encouraged to discuss treatment options with patients who are at a higher risk of severe illness from influenza, COVID-19 and Respiratory Syncytial Virus (RSV) before they get sick and create a plan to ensure patients receive the appropriate therapeutic within the treatment window. Influenza Antiviral medications (Tamiflu and Relenza) may be used for both the prevention and treatment of influenza and should be given as soon as possible and optimally within 48 hours of symptom onset. Laboratory confirmation is not required to initiate antiviral treatment and may be discontinued if testing identifies an alternate pathogen. COVID-19 Treatment for COVID-19 must be administered early in the course of illness; Paxlovid must begin within five days of symptom onset, and Remdesivir within seven days of symptom onset. Learn how to access COVID-19 treatments for patients in the community. RSV RSV prophylaxis for high-risk infants (Palivizumab) works best if started as early as possible to prevent illness. More Information REVIEW: Centre de santé Communautaire - Caring for my COPD - Welland Pulmonary Rehabilitation ProgramAs winter approaches, so does the dreaded Cold and Influenza season. Health Care professionals may see an increased number of calls/visits from patients with COPD. The pulmonary rehabilitation program continues to offer services virtually as well as in person with reduced group sizes. The Canadian Thoracic Society recommends pulmonary rehab for the treatment of COPD. Program Overview (Free)
Who is Eligible?
How to Refer
REVIEW: Opioid and Safer Supply ResourcesDid you know Public Health has an Opioid and Safer Supply Resources webpage? Visit the Opioid and Safer Supply Resources webpage for:
The College of Physicians and Surgeons of Ontario recognizes that providing pharmaceutical-grade alternatives to the toxic street supply, both in the context of a comprehensive treatment plan or as a standalone harm reduction strategy, can enable physicians to support patients with opioid use disorder and reduce their risk of overdose and death. See their advice to the profession about prescribing drugs. ![]() REVIEW: National Breastfeeding WeekThis year, National Breastfeeding Week was celebrated from October 1 to 7, 2023. Niagara Region Public Health is here to help you support patients in navigating breastfeeding support in the community. Niagara Region Public Health offers one-on-one infant feeding support from a public health nurse who can answer questions related to breastfeeding, bottle feeding, and transitioning to solids. How to Refer
![]() FREE TRAINING: Breastfeeding "Making a Difference" Level 2 - Last Chance to Register!Niagara Region Public Health is hosting a 2-day virtual (LIVE) workshop series for community health care professionals and hospital staff practicing in Niagara who currently work with expectant or new parents and families. When: This series will take place over Zoom on November 7 and November 14, 2023 from 8:30 a.m. – 4:00 p.m. Keynote Speaker: Kathleen O’Grady is a registered nurse and an International Board Certified Lactation Consultant (IBCLC). Please see: Breastfeeding: Making a Difference Level 2 Workshop - Niagara Region, Ontario, for her additional credentials. Key Topics
Requirements:
Note: Participants must attend both session dates and may be eligible to receive IBLCE CERPS (Continuing Education Recognition Points). The event is live for registration on the Professional Development Opportunities Page . Registration Deadline: October 31, 2023 ![]() ![]() |